Michael Klichinsky
Founder presso CARISMA THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Michael Klichinsky is the founder.
He founded CTx Operations, Inc. in 2016 and holds the title of Chief Scientific Officer.
He also founded Carisma Therapeutics, Inc. in 2016 and holds the title of Chief Scientific Officer.
Dr. Klichinsky has a doctorate degree from the University of Pennsylvania and a doctorate degree from the University of the Sciences in Philadelphia.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/01/2024 | 484 347 ( 1.20% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Michael Klichinsky
| Società | Posizione | Inizio |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Founder | 01/01/2016 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Founder | 01/01/2016 |
Formazione di Michael Klichinsky
| University of Pennsylvania | Doctorate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Michael Klichinsky
